Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Single Dose, One-Day Early Administration, Multicentre Study Comparing the Efficacy and Safety of Acyclovir Lauraid 50 mg Muco-Adhesive Buccal Tablet to Matching Placebo, in the Treatment of Herpes Labialis in Im

Stony Brook University

Project: Research

Project Details

StatusFinished
Effective start/end date10/23/07 → 09/15/10

Funding

  • BioAlliance Pharma SA: $21,972.50